BSE filing, NSE: MAYUKH. Summary written from the filing by ALFA Finder's alert engine.
Sattva Sukun Lifecare Ltd: key numbers
- Share price
- ₹1.15
- Market cap
- ₹44.11 Cr
- Revenue (annual)
- ₹32.25 Cr
- Net profit (annual)
- ₹0.11 Cr
- P/E (TTM)
- -28.5×Sector 46.8×
- Promoter holding
- 3.65%-2.74% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sattva Sukun Lifecare Ltd
All →Sattva Sukun Lifecare Other Announcement
Tavexia Lifecare Ltd board approved changing its RTA from Niche Technologies to Skyline Financial Services. Niche continues until data transition and depository confirmations are complete.
Sattva Sukun Lifecare Q2 FY27 Results: Net Loss of ₹0.4 Cr
Sattva Sukun Lifecare Ltd reported revenue from operations of ₹5 Cr (-70.2% YoY) and a net loss of ₹0.4 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.4 Cr
Sattva Sukun Lifecare Board Meeting Date
Tavexia Lifecare has scheduled a board meeting for November 4, 2026 to consider Q2 results, RTA change, and a fund-raise proposal. All items are proposed only.
Sattva Sukun Lifecare Other Announcement
Tavexia Lifecare Ltd submitted its quarterly shareholding pattern report for the period ended September 30, 2026, in compliance with SEBI regulations.
Sattva Sukun Lifecare Acquisition Worth ₹67.19 Cr
Tavexia Lifecare will acquire a 60% stake in Meyonex Pharmaceuticals Limited for ₹67.19 Crore. This strategic investment aims to expand its pharmaceutical sector presence.
- Value
- ₹67.19 Cr
Sattva Sukun Lifecare Annual General Meeting
Tavexia Lifecare Limited concluded its 46th Annual General Meeting on September 30, 2026. Shareholders approved the financial statements, auditor appointment, related party transactions, and director re-appointment.
Other adverse business impact announcements
All →Konstelec Engineers Adverse Business Impact
Konstelec Engineers' registered office building was hit by a fire, and access has been restricted for about 10 days. Unaudited results for the quarter and half year ended September 30, 2026 are now expected by November 30, 2026.
Kanco Tea & Industries Adverse Business Impact
Kanco Tea & Industries disclosed a revised update on natural-calamity damage at its Bmaonpookrie Tea Estate. It has received Rs.224 lakhs from insurers, and the production loss is valued at Rs.303.41 lakhs.
- Value
- ₹3.03 Cr
Hindustan Organic Chemicals Adverse Business Impact
Hindustan Organic Chemicals will shut its Kochi phenol plant for about one week to replace a damaged hydrogen supply line. The shutdown is followed by hydrotesting and restoration work.
- Execution
- approximately one week
Gokaldas Exports Adverse Business Impact
Gokaldas Exports disclosed that a customer of its step-down subsidiary, The Children's Place, filed for Chapter 11 bankruptcy in the US. The subsidiary has a USD 4.11 Mn receivable from that customer, and the company is assessing the impact.
- Value
- ₹38.63 Cr
Medplus Health Services Adverse Business Impact
MedPlus stores in Karnataka face four-day drug licence suspensions. Expected financial impact is about Rs 4.06 lacs.
- Value
- ₹0.04 Cr
- Execution
- Four days
GRE Renew Enertech Adverse Business Impact
GRE Renew Enertech received Urjasol Energy's request to cancel a solar EPC purchase order. The company acknowledged the cancellation on 7 November 2026.
- From
- Urjasol Energy Private Limited